Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 270
Review: Parkinson's disease: from synaptic loss to connectome dysfunction
Arianna Bellucci, Nicola Biagio Mercuri, Annalena Venneri, et al.
Neuropathology and Applied Neurobiology (2015) Vol. 42, Iss. 1, pp. 77-94
Open Access | Times Cited: 194
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 91
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate
Elisa Belluzzi, Adriano Gonnelli, Maria‐Daniela Cirnaru, et al.
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 164
Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice
Emilie Giaime, Youren Tong, Lisa Katharina Wagner, et al.
Neuron (2017) Vol. 96, Iss. 4, pp. 796-807.e6
Open Access | Times Cited: 115
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1406-1422
Open Access | Times Cited: 91
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong, Stewart Neifert, Senthilkumar S. Karuppagounder, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 7, pp. 1635-1640
Open Access | Times Cited: 86
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Francesco Longo, Daniela Mercatelli, Salvatore Novello, et al.
Acta Neuropathologica Communications (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 87
Models of LRRK2-Associated Parkinson’s Disease
Yulan Xiong, Ted M. Dawson, Valina L. Dawson
Advances in neurobiology (2017), pp. 163-191
Open Access | Times Cited: 71
LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis
Mattia Volta, Heather L. Melrose
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 113-122
Closed Access | Times Cited: 64
The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction
Edward Pajarillo, Sang Hoon Kim, Alexis Digman, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 7, pp. 104879-104879
Open Access | Times Cited: 22
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Alessandro Tozzi, Michela Tantucci, Saverio Marchi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 47
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
Meghan L. Bucher, Caitlyn W. Barrett, Connor Moon, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 44
Progress in LRRK2-Associated Parkinson’s Disease Animal Models
Steven P. Seegobin, George R. Heaton, Dongxiao Liang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 41
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Eunice Eun Seo Chang, Philip Wing‐Lok Ho, Huifang Liu, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson’s disease-like non-motor symptoms without loss of dopamine neurons
Won‐Seok Choi, Hyung-Wook Kim, François Tronche, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 48
G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice
Nicolas Arbez, XiaoFei He, Yong Huang, et al.
Human Molecular Genetics (2019) Vol. 29, Iss. 4, pp. 580-590
Open Access | Times Cited: 37
Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
Yulan Xiong, Stewart Neifert, Senthilkumar S. Karuppagounder, et al.
eNeuro (2017) Vol. 4, Iss. 2, pp. ENEURO.0004-17.2017
Open Access | Times Cited: 37
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 29
LRRK2 at the pre‐synaptic site: A 16‐years perspective
Francesca Pischedda, Giovanni Piccoli
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 297-311
Open Access | Times Cited: 29
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2025)
Open Access
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson’s disease
Martina Gregori, Gustavo J.S. Pereira, Robert Allen, et al.
The Journal of Cell Biology (2025) Vol. 224, Iss. 6
Open Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
eLife (2025) Vol. 13
Open Access
Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease
Ping‐Yue Pan, Yingbo Zhu, Yuan Shen, et al.
Neurobiology of Disease (2018) Vol. 122, pp. 64-71
Open Access | Times Cited: 30
Targeting the cannabinoid CB 2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice
Cristina Palomo‐Garo, Yolanda Gómez‐Gálvez, Concepción García, et al.
Pharmacological Research (2016) Vol. 110, pp. 181-192
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top